These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate]. Lobuseva AN, Kuznetsova SM, Samoĭlova LN. Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515 [Abstract] [Full Text] [Related]
5. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic]. Ravagnan G, Rasura M, Piccolomini R. Boll Soc Ital Biol Sper; 1976 Sep 30; 52(18):1440-6. PubMed ID: 1024552 [No Abstract] [Full Text] [Related]
6. The susceptibility of recently isolates of gram-negative bacteria to amikacin and other aminoglycosides. Lexomboon U, Duangmani C, Srimunta C. J Med Assoc Thai; 1979 Oct 30; 62(10):544-9. PubMed ID: 501262 [No Abstract] [Full Text] [Related]
12. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin]. Cuena Boy R, Azanza Perea JR, Echeverría Echepare LM, Honorato Pérez J. Rev Med Univ Navarra; 1983 Dec 30; 27(4):21-7. PubMed ID: 6676898 [No Abstract] [Full Text] [Related]
15. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics]. García Hierro P, Ponte Miramontes MC, Soriano García F. Rev Clin Esp; 1980 Oct 31; 159(2):87-90. PubMed ID: 7209044 [No Abstract] [Full Text] [Related]
20. [Control of the resistance of gram-negative bacilli to aminoglucosides. Results of a 3-year prospective study with the exclusive use of amikacin]. Ruiz-Palacios G, Ponce de León S, Sifuentes J, Ponce de León S, Calva J, Huazano F, Ontiveros C, Ojeda F, Bobadilla M. Rev Invest Clin; 1986 Oct 25; 38(1):1-6. PubMed ID: 3738260 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]